Dr Reddy’s Laboratories Limited along with its subsidiaries together on Saturday launched Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules, a therapeutic equivalent generic version of Vitamin K1 (Phytonadione) Injectable Emulsion USP, 10 mg/ml, approved by the U S Food and Drug Administration (USFDA).
“We’re pleased to bring this product to market for the customers and patients who will benefit from access to this medicine and who have in the past experienced supply disruptions in the market place,” said Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s Laboratories.
“This is a great addition to our injectable offering in the US market as we continue to augment our portfolio to drive growth for the Global Hospitals segment,” he added.
The Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic had combined US sales of approximately USD 46.6 million MAT for the most recent twelve months ending in April 2019 according to IQVIA Health.
Dr Reddy’s Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules is available in 1 mL Ampule containing 10 mg/mL of Phytonadion, a company statement here said.
